Corporate Social Responsibility Report (Chinese edition)

Overview

The report describes Fosun Pharma's 2018 sustainability performance across innovation, environmental management, employees and public welfare. The company invested 25.07亿元 in R&D, while reporting group carbon emissions of 786,371 tonnes and extensive energy-saving initiatives. It also highlights more than 1,200万元 in targeted poverty-alleviation investment, alongside health-focused donations and rural healthcare programs.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2018
Period: 1 January 2018 – 31 December 2018
Language: Chinese
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services